Natural CD4 CD25+ regulatory T cells control the burst of superantigen-induced cytokine production:: the role of IL-10

被引:50
作者
Pontoux, C [1 ]
Banz, A [1 ]
Papiernik, M [1 ]
机构
[1] Inst Necker, INSERM, U345, F-75730 Paris 15, France
关键词
CD4 CD25(+); cytokines; IL-10; regulatory CD4 T cells; superantigen;
D O I
10.1093/intimm/14.2.233
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In normal mice a subpopulation of CD4 T cells constitutively expresses the IL-2 receptor alpha chain (CD25). This natural CD4 CD25(+) subset is thymus-born, constitutively expresses IL-10 mRNA, does not produce IL-2 and Is resistant to apoptosis. These cells behave as regulatory T cells in the control of self-tolerance, inflammatory reactions and T cell homeostasis. The mechanisms by which natural CD4 CD25(+) cells control the immune response is unclear. We examined CD25-deficient mice, which over-express various cytokines, including proinflammatory molecules, after bacterial superantigen stimulation in vivo. We observed that this abnormal cytokine production could be controlled by the injection of natural CD4 CD25(+) T cells and that IL-10 production is needed, as CD4 CD25(+) T cells from IL-10 knockout mice do not correct cytokine over-production In vivo. As the circulating IL-10 produced by CD25-deficient mice was ineffective, we deduced that the key source of IL-10 was the regulatory T cell population. IL-10 is also involved in the control of cytokine production by normal T cells. However, the target of IL-10 in this control is undefined. Whether it acts directly on the effector T cells or on the regulatory CD4 CD25(+) T cells themselves to induce their functional maturation has to be clarified.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 33 条
[1]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[2]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[3]   T helper cell 1-type CD4(+) T cells, but not B cells, mediate colitis in interleukin 10-deficient mice [J].
Davidson, NJ ;
Leach, MW ;
Fort, MM ;
ThompsonSnipes, L ;
Kuhn, R ;
Muller, W ;
Berg, DJ ;
Rennick, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :241-251
[4]   LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN [J].
DISANTO, JP ;
MULLER, W ;
GUYGRAND, D ;
FISCHER, A ;
RAJEWSKY, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :377-381
[5]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[6]  
Haskó G, 1998, EUR J IMMUNOL, V28, P1417, DOI 10.1002/(SICI)1521-4141(199804)28:04<1417::AID-IMMU1417>3.0.CO
[7]  
2-L
[8]  
Itoh M, 1999, J IMMUNOL, V162, P5317
[9]   INTERLEUKIN-10-DEFICIENT MICE DEVELOP CHRONIC ENTEROCOLITIS [J].
KUHN, R ;
LOHLER, J ;
RENNICK, D ;
RAJEWSKY, K ;
MULLER, W .
CELL, 1993, 75 (02) :263-274
[10]   Type 1 IFN maintains the survival of anergic CD4+ T cells [J].
Lombardi, G ;
Dunne, PJ ;
Scheel-Toellner, D ;
Sanyal, T ;
Pilling, D ;
Taams, LS ;
Life, P ;
Lord, JM ;
Salmon, M ;
Akbar, AN .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3782-3789